Stockreport

The Scoop On Mindset Pharma’s Next-Generation Psilocybin And 5-MeO-DMT [Forbes]

Trillium Therapeutics Inc. - Common Shares  (TRIL) 
Last trillium therapeutics inc. - common shares earnings: 5/13 07:00 am Check Earnings Report
PDF Mindset Pharma CEO James Lanthier says their next-generation psychedelic drug development involves... [+]making "careful changes to their chemical structures, in order t [Read more]